Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04417166Phase 2Active Not Recruiting
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
Lymphoma, Extranodal NK-T-Cell
StudychairStart date: 2022-02-11

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Shanghai Rui Jin Hospital,Shanghai Jiao Tong University - School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

yue lu, MD.

Department of Hematological Oncology, Sun Yat-sen University Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Wyndham H Wilson, M.D.

National Cancer Institute (NCI)

Moderately Similar
7 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

ZhongJun Xia, MD/PHD

Department of Hematological Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China,

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Helen Heslop, MD

Baylor College of Medicine

Moderately Similar
17 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

James N Kochenderfer, M.D.

National Cancer Institute (NCI)

Moderately Similar
11 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Jinhua Liang

he First Affiliated Hospital with Nanjing Medical University, Nanjing, China

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Pablo Ortiz, MD, PhD

Hospital 12 de Octubre

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Ting Liu, MD

West China Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Kurt Gunter, MD

Cell Medica

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Wonseog Kim, M.D

Samsung Medical Center

Moderately Similar
2 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04417166Phase 2StudyChair

Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma

Lymphoma, Extranodal NK-T-Cell
Active Not Recruiting

All 1 trials loaded